Promus - Registry Experience at the Washington Hospital Center, Drug-eluting Stent (DES)
- Conditions
- Coronary Artery Disease
- Registration Number
- NCT01003795
- Lead Sponsor
- Medstar Health Research Institute
- Brief Summary
Single-center registry of patients treated with at least one Promus, everolimus-eluting, Stent, with the primary objective to assess clinical success and safety at 30 days, 6 months and 1 year post-implantation.
- Detailed Description
Interventional cardiology was revolutionized by the invention of stents, initially with the bare-metal stents (BMS) and recently with the drug-eluting stents (DES). The everolimus eluting stents have shown very promising results in randomized clinical trials, demonstrating a reduction of clinical and angiographic restenosis in comparison to BMS, and comparable clinically-driven target lesion revascularization rates in comparison with sirolimus-eluting stents. While registry data is available from outside of the United States, it will be important to collect "real-world" data regarding the stent usage and outcomes in the United States. In this study we propose to follow patients who received at least one Promus® Stent for at least 1 year post initial stent implantation.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Patients, male or female, >18 years of age
- Patients who received at least one Promus drug-eluting stent at the Washington Hospital Center
- N/A
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of Major Adverse Cardiac Events (MACE) post Promus Stent implantation Follow up
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Washington Hospital Center
🇺🇸Washington, District of Columbia, United States